DiaMedica Therapeutics Inc.·4

Jul 25, 4:35 PM ET

JACINTO RICHARD II 4

4 · DiaMedica Therapeutics Inc. · Filed Jul 25, 2025

Insider Transaction Report

Form 4
Period: 2025-07-23
Transactions
  • Purchase

    Voting Common Shares, no par value per share

    2025-07-23$3.50/sh+400,000$1,400,0004,958,823 total(indirect: By IRA)
Footnotes (1)
  • [F1]These shares are held by NFS/FMTC Roth IRA FBO Richard Jacinto II, of which Richard Jacinto II is the beneficiary.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4